Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vaccine

FPAI launches nation-wide vaccine drive against cervical cancer

FPAI launches HPV Vaccination drive across India to vaccinate girls & women against cervical cancer. Donations reduce cost to ₹1,350/dose.

The Hindu

Why Isn’t There a Vaccine for the Common Cold? A Virologist Reveals the Hidden Reason

If we can create a vaccine for a novel virus in under a year, what’s stopping scientists from inoculating us against the sniffles?

Inverse

Of love letters and distant galaxies: Uplifting stories from 2023

It was a turbulent year from start to end, but 2023 was not just about devastating wars, natural disasters and the cost-of-living crisis. The past 12 months also saw the approval of a revolutionary new malaria vaccine, a sharp drop in the deforestation of the Amazon, and an historic victory…

France 24

From analysis to the latest developments in health,
read the most diverse news in one place.

New COVID variant JN.1: Health Ministry says no need for booster dose

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India.

The Hindu

New CDC advisory urges updated vaccines to protect against respiratory illnesses

Get the latest scoop on respiratory illnesses and vaccines from primary care physician and public health specialist, Dr. Saju Matthew. With a creative tone...

Top News

The biggest Fox News fails of 2023

The right-wing network ends a tough year on a low note — with more trouble ahead in 2024

Salon

JN.1—a new, highly mutated COVID variant—could cause one of the largest U.S. waves yet, experts say. When each state could see the variant peak

This year's winter respiratory disease season was looking to be a bit of a respite from last year's—until JN.1 took off. Now, it's anyone's best guess.

Fortune

Read news from The Economist, FT, and more,
with one subscription

COVID vaccine rates plummet but antiviral use up, as COVID cases rise

'Still a lot of COVID around' and 36 in hospital in district.

Newcastle Herald

As JN.1 emerges as variant of interest, time to evaluate preparedness and effective testing and treatments

WHO classifies JN.1 as a separate variant of interest (VOI) with potential to affect virus characteristics & increase burden of respiratory infections. Vaccines expected to increase protection against JN.1. India detects 21 cases, all mild.

The Hindu

WHO prequalifies a second malaria vaccine manufactured by Serum Institute of India

WHO prequalifies R21/Matrix-M malaria vaccine to increase access & prevent malaria in children.

The Hindu

Doctors fear NHS could buckle in flu season as staff avoid vaccine

Exclusive: Less than 40 per cent of frontline staff were vaccinated ahead of winter, risking staff shortages and flu transmission

The Independent UK

Second malaria vaccine prequalified by WHO: Know what this means

The World Health Organisation (WHO) has added the second malaria vaccine to its list of prequalified vaccines. The vaccine, R21/ Matrix-M malaria vaccine, was recommended by the WHO for malaria treatment in October 2023. The R21 vaccine is the second malaria vaccine prequalified by the WHO, following the RTS, S/AS01…

The Times of India

JN.1: What to know about the new Covid variant surging in the US

Infectious disease experts say the best way to protect yourself from the JN.1 subvariant is to get the updated Covid 19 vaccine

The Independent UK

Pfizer Sues Poland And Hungary Over Covid Debts

Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines ordered during the Covid pandemic, lawyers said Tuesday.

International Business Times

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Victorian Britain had its own anti-vaxxers – and they helped bring down a government

As the 1906 UK general election results rolled in, it became clear that the Conservative party, after 11 years in power, had suffered one of the most disastrous defeats in its history. Of 402 Conservative MPs, 251 lost their seats, including their candidate for prime minister, defeated on a 22.5%…

The Conversation

mRNA COVID vaccines make 'unintended proteins' – we've discovered how to fix this problem

MRNA, a type of genetic material that provides the instructions your cells need in order to make proteins, used to be a term mainly used by scientists. But since COVID arrived many of us are now familiar with it thanks to the mRNA-based vaccines.

The Hindu

mRNA, easy to customise, is the next frontier for personalised medicine

Because it is so easy to change the mRNA recipes, cancer vaccines can be part of a personalized medicine plan where doctors sample a patient’s tumour, sequence key genes and adjust the mRNA treatment to include recipes specific to that patient’s cancer. Clinical trials using this personalized approach for pancreatic…

Medical Daily

Get Your Shots Immediately: CDC Warns Of 'Urgent Need' To Boost Vaccine Coverage As Respiratory Illnesses Surge

Low vaccination rates against influenza, COVID-19 and RSV, along with an increase in respiratory diseases, could pose a potential strain on the healthcare system, the CDC warned.

Get all your
news in one place.

100’s of premium titles.
One news app.

Latin Times

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Globally there were an estimated 325,000 new melanoma cases and 57 ,000 deaths from the disease in 2020.

Top News

Moderna Tests Promising Personalized Skin Cancer Vaccine with 49% Improvement!

Moderna tests a novel approach to battle skin cancer, with a vaccine showing benefits for melanoma patients. Treatment could be available by 2025.

International Business Times

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer.

The Conversation

CRISPR and other new technologies open doors for drug development, but which diseases get prioritized? It comes down to money and science

Prescription drugs and vaccines revolutionized health care, dramatically decreasing death from disease and improving quality of life across the globe. But how do researchers, universities and hospitals, and the pharmaceutical industry decide which diseases to pursue developing drugs for?

The Hindu

Special vaccination camp launched for children

Health Dept launches special camp in Chennai to provide Measles-Rubella vaccine to 27.42 lakh children aged 9 months-15 years in cyclone-hit districts. 10 lakh doses sought from Union govt. 6,421 camps organised, 4.69 lakh persons benefited, 6,403 with fever, 71,561 with cough/cold.

The Conversation

Health misinformation is rampant on social media – here's what it does, why it spreads and what people can do about it

The global anti-vaccine movement and vaccine hesitancy that accelerated during the COVID-19 pandemic show no signs of abating.

AAP

COVID-19 pandemic response continues to press on budget

Continuing to pay for COVID-19 vaccines and treatments will cost Australians hundreds of millions of dollars, with the threat posed by the virus far from over.

1 … 91 92 93 94

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.